307 related articles for article (PubMed ID: 23801148)
1. Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management.
Soares CN
Drugs Aging; 2013 Sep; 30(9):677-85. PubMed ID: 23801148
[TBL] [Abstract][Full Text] [Related]
2. Mood disorders in midlife women: understanding the critical window and its clinical implications.
Soares CN
Menopause; 2014 Feb; 21(2):198-206. PubMed ID: 24448106
[TBL] [Abstract][Full Text] [Related]
3. Hormone therapy and mood in perimenopausal and postmenopausal women: a narrative review.
Toffol E; Heikinheimo O; Partonen T
Menopause; 2015 May; 22(5):564-78. PubMed ID: 25203891
[TBL] [Abstract][Full Text] [Related]
4. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
5. Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause.
Soares CN; Poitras JR; Prouty J
Drugs Aging; 2003; 20(2):85-100. PubMed ID: 12534310
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations.
Maki PM; Kornstein SG; Joffe H; Bromberger JT; Freeman EW; Athappilly G; Bobo WV; Rubin LH; Koleva HK; Cohen LS; Soares CN
J Womens Health (Larchmt); 2019 Feb; 28(2):117-134. PubMed ID: 30182804
[TBL] [Abstract][Full Text] [Related]
7. Progression of female reproductive stages associated with bipolar illness exacerbation.
Marsh WK; Ketter TA; Crawford SL; Johnson JV; Kroll-Desrosiers AR; Rothschild AJ
Bipolar Disord; 2012 Aug; 14(5):515-26. PubMed ID: 22650986
[TBL] [Abstract][Full Text] [Related]
8. Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement.
Stute P; Spyropoulou A; Karageorgiou V; Cano A; Bitzer J; Ceausu I; Chedraui P; Durmusoglu F; Erkkola R; Goulis DG; Lindén Hirschberg A; Kiesel L; Lopes P; Pines A; Rees M; van Trotsenburg M; Zervas I; Lambrinoudaki I
Maturitas; 2020 Jan; 131():91-101. PubMed ID: 31740049
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations.
Maki PM; Kornstein SG; Joffe H; Bromberger JT; Freeman EW; Athappilly G; Bobo WV; Rubin LH; Koleva HK; Cohen LS; Soares CN;
Menopause; 2018 Oct; 25(10):1069-1085. PubMed ID: 30179986
[TBL] [Abstract][Full Text] [Related]
10. Hormonal Agents for the Treatment of Depression Associated with the Menopause.
Herson M; Kulkarni J
Drugs Aging; 2022 Aug; 39(8):607-618. PubMed ID: 35908135
[TBL] [Abstract][Full Text] [Related]
11. Cognition in perimenopause: the effect of transition stage.
Weber MT; Rubin LH; Maki PM
Menopause; 2013 May; 20(5):511-7. PubMed ID: 23615642
[TBL] [Abstract][Full Text] [Related]
12. Menopause and Mood: The Role of Estrogen in Midlife Depression and Beyond.
Soares CN
Psychiatr Clin North Am; 2023 Sep; 46(3):463-473. PubMed ID: 37500244
[TBL] [Abstract][Full Text] [Related]
13. Bioidentical Estrogen for Menopausal Depressive Symptoms: A Systematic Review and Meta-Analysis.
Whedon JM; KizhakkeVeettil A; Rugo NA; Kieffer KA
J Womens Health (Larchmt); 2017 Jan; 26(1):18-28. PubMed ID: 27603786
[TBL] [Abstract][Full Text] [Related]
14. Does risk for anxiety increase during the menopausal transition? Study of women's health across the nation.
Bromberger JT; Kravitz HM; Chang Y; Randolph JF; Avis NE; Gold EB; Matthews KA
Menopause; 2013 May; 20(5):488-95. PubMed ID: 23615639
[TBL] [Abstract][Full Text] [Related]
15. Effect of symptoms of climacteric syndrome, depression and insomnia on self-rated work ability in peri- and post-menopausal women in non-manual employment.
Humeniuk E; Bojar I; Gujski M; Raczkiewicz D
Ann Agric Environ Med; 2019 Dec; 26(4):600-605. PubMed ID: 31885234
[TBL] [Abstract][Full Text] [Related]
16. Challenges and opportunities to manage depression during the menopausal transition and beyond.
Soares CN; Frey BN
Psychiatr Clin North Am; 2010 Jun; 33(2):295-308. PubMed ID: 20385338
[TBL] [Abstract][Full Text] [Related]
17. Menopausal symptoms among Chinese peri- and postmenopausal women: a large prospective single-center cohort study.
Zhang L; Ruan X; Cui Y; Gu M; Mueck AO
Gynecol Endocrinol; 2021 Feb; 37(2):185-189. PubMed ID: 33054449
[TBL] [Abstract][Full Text] [Related]
18. Sex hormones and mood in the perimenopause.
Schmidt PJ; Rubinow DR
Ann N Y Acad Sci; 2009 Oct; 1179():70-85. PubMed ID: 19906233
[TBL] [Abstract][Full Text] [Related]
19. A woman's journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement.
Stevenson JC
Maturitas; 2011 Oct; 70(2):197-205. PubMed ID: 21788109
[TBL] [Abstract][Full Text] [Related]
20. Associations among depression, anxiety and somatic symptoms in peri- and postmenopausal women.
Terauchi M; Hiramitsu S; Akiyoshi M; Owa Y; Kato K; Obayashi S; Matsushima E; Kubota T
J Obstet Gynaecol Res; 2013 May; 39(5):1007-13. PubMed ID: 23379427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
